

[ Thu, Dec 23rd 2021
] - WOPRAI
[ Thu, Dec 23rd 2021
] - WOPRAI
[ Thu, Dec 23rd 2021
] - WOPRAI
[ Thu, Dec 23rd 2021
] - WOPRAI
[ Thu, Dec 23rd 2021
] - WOPRAI

[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
Sumant Kulkarni Maintained (ACAD) at Hold with Increased Target to $30 on, Dec 22nd, 2021
Sumant Kulkarni of Canaccord Genuity, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $26 to $30 on, Dec 22nd, 2021.
Sumant has made no other calls on ACAD in the last 4 months.
There are 9 other peers that have a rating on ACAD. Out of the 9 peers that are also analyzing ACAD, 7 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Neena Bitritto-Garg of "Citigroup" Maintained at Hold with Increased Target to $30 on, Tuesday, December 21st, 2021
- Tazeen Ahmad of "B of A Securities" Maintained at Hold with Increased Target to $32 on, Tuesday, December 21st, 2021
- Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold and Held Target at $28 on, Tuesday, December 21st, 2021
- Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $23 on, Thursday, December 9th, 2021
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $28 on, Wednesday, December 8th, 2021
- Vamil Divan of "Mizuho" Maintained at Hold with Increased Target to $26 on, Tuesday, December 7th, 2021
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $24 on, Tuesday, December 7th, 2021
These are the ratings of the 2 analyists that currently disagree with Sumant
- Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $34 on, Tuesday, December 21st, 2021
- Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $42 on, Tuesday, December 21st, 2021
Contributing Sources